Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar

    July 2021 in “ Acta dermatovenerologica Croatica ”
    Ivona Lovrić, Jelena Brkić, Matea Ćorluka … Jasna Zeljko Penavić
    Studysummary This case report describes regression of hidradenitis suppurativa lesions in two patients after 16 weeks of adalimumab treatment.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on pubmed.ncbi.nlm.nih.gov →
    Discuss this study in the Community →